Watch now
Fill in your details to watch the webinar.
Unlocking the potential of hyper-collaboration in Life Sciences: Accelerate breakthroughs together
Great collaboration is the foundation of great business. But for Life Sciences, especially post-covid the expectation on the industry has increased, where people's health is on the line, it is critical.
Join Ideagen and AstraZeneca's R&D IT Capability Lead for CMC, Sophie Bailes, as we delve into the transformative power of hyper-collaboration in the life sciences industry.
In today's interconnected world, where challenges are increasingly complex, no single person or team can tackle the vast number of scientific, technological and medical frontiers alone. The key to accelerating breakthroughs lies in leveraging diverse expertise and fostering a culture of collaboration that transcends organisational boundaries.
During this webinar, we will explore the critical role of hyper-collaboration in driving innovation and propelling speed to market, while supporting compliance and regulatory requirements.
Join us to learn:
- What hyper-collaboration is and why its so important in the industry today - "Science is a team sport"
- How AstraZeneca have fostered a culture of collaboration and harnessed technology to reduce risk and improve output - "Science meets digital"
- The tools available today to make hyper-collaboration a reality in your organisation - "Driving collaboration day-to-day"
Sophie joined AstraZeneca in 2005 and has held a number of leading roles across chemical development and product development; delivering drug projects from Phase 1 to commercial submission, and science & technology improvement projects. For the past 3 years, Sophie has lead digital transformation program, delivering a new digital backbone for data capture, use, and reuse for 1250 scientists across 9 development sites.
Her cross disciplinary team has deployed a number of digital solutions, integrating key software and equipment to deliver a seamless data transfer, increasing data quality, and reducing time required for data handling. Sophie has successfully lead the design, build, and deployment of critical software and capability build required to increase predictive science, advanced modelling, and data science capabilities, allowing scientists to innovate in a simulated environment thereby targeting physical experiments and reducing laboratory waste.
Sophie has a PhD in Separation Science with research focused on modelling separation mechanisms of complex polar molecules, she is a Chartered Chemist with Royal Society of Chemistry. Sophie has a diploma in Business Management and is a Chartered Manager with CMI. Sophie is a co-chair of the AZ Pride Ireland and UK group and is passionate about driving equality both inside and outside work. She lives in central Manchester with her miniature dachshund called Data, who is the most important asset in her world.
Tags: